Efficacy and predictors of short-term first-generation somatostatin analog presurgical treatment in acromegaly: A hospital-based study of 237 cases

被引：11

作者：

Shen, Ming ^{[1
,3
,5
,6
,7
]}

Yang, Yeping ^{[2
]}

He, Wenqiang ^{[1
,3
,5
,6
,7
]}

Qiao, Nidan ^{[1
,3
,5
,6
,7
]}

He, Min ^{[2
,3
]}

Shou, Xuefei ^{[1
,3
,5
,6
,7
]}

Wang, Meng ^{[2
]}

Ma, Zengyi ^{[1
,3
,5
,6
,7
]}

Ye, Zhao ^{[1
,3
,5
,6
,7
]}

Zhang, Yichao ^{[1
,3
,5
,6
,7
]}

Chen, Zhengyuan ^{[1
,3
,5
,6
,7
]}

Zhang, Qilin ^{[1
,3
,5
,6
,7
]}

Zhou, Xiang ^{[1
,3
,5
,6
,7
]}

Cao, Xiaoyun ^{[1
,3
,5
,6
,7
]}

Ye, Hongying ^{[2
,3
]}

Wang, Yongfei ^{[1
,3
,5
,6
,7
]}

Li, Shiqi ^{[1
,3
,5
,6
,7
]}

Li, Yiming ^{[2
,3
]}

Zhao, Yao ^{[1
,3
,4
,5
,6
,7
]}

Zhang, Zhaoyun ^{[2
,3
,4
]}

机构：

[1] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China

[2] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200040, Peoples R China

[3] Shanghai Pituitary Tumor Ctr, Shanghai 200040, Peoples R China

[4] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai 200040, Peoples R China

[5] Fudan Univ, Neurosurg Inst, Shanghai 200040, Peoples R China

[6] Shanghai Clin Med Ctr Neurosurg, Shanghai 200040, Peoples R China

[7] Shanghai Key Lab Brain Funct & Restorat & Neural, Shanghai 200040, Peoples R China

来源：

GROWTH HORMONE & IGF RESEARCH | 2020年 / 55卷

基金：

中国国家自然科学基金;

关键词：

Acromegaly; Growth hormone-secreting pituitary adenoma; Presurgical treatment; Somatostatin analogs; Granulation pattern; PREOPERATIVE OCTREOTIDE TREATMENT; SECRETING PITUITARY-ADENOMAS; GROWTH-HORMONE; CLINICOPATHOLOGICAL FEATURES; TUMOR VOLUME; THERAPY; PATTERN; RATES;

D O I：

10.1016/j.ghir.2020.101354

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Objective: To investigate the effectiveness and predictors of short-term somatostatin analog (SSA) presurgical therapy in a large cohort and to assess the correlation between clinical and pathological variables. Design: 237 newly diagnosed patients with acromegaly received presurgical SSA treatment for three months were recruited. Clinical characteristics were collected, and response to SSA in hormone and tumor size was evaluated. The correlation between clinical information and pathological variables were analyzed. Results: After 3 months presurgical SSA therapy, 51 (21.5%) patients were biochemically responsive with 2 cm and age 2 cm, patients with MTD 49 years than <= 49 years (48.1% and 31.0% P = 0.089). Conclusions: The baseline MTD and age correlate with granulation patterns and may be used as easily acquired predictors of presurgical SSA treatment in acromegaly. Patients over their 50s with a tumor less than 2 cm in diameter are more likely to have a response to the short-term presurgical SSA therapy.

引用

页数：6

共 28 条

[11] Mortality in acromegaly: A meta analysis
Dekkers, O. M.
Biermasz, N. R.
Pereira, A. M.
Romijn, J. A.
Vandenbroucke, J. P.
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01) : 61 - 67
[12] DICHIRO G, 1962, AMER J ROENTGENOL RA, V87, P989
[13] Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial
Fougner, S. L.
Bollerslev, J.
Svartberg, J.
Oksnes, M.
Cooper, J.
Carlsen, S. M.
[J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (02) : 229 - 235
[14] The nadir growth hormone after an octreotide test dose predicts the long-term efficacy of somatostatin analogue therapy in acromegaly
Gilbert, JA
Miell, JP
Chambers, SM
McGregor, AM
Aylwin, SJB
[J]. CLINICAL ENDOCRINOLOGY, 2005, 62 (06) : 742 - 747
[15] Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
Giustina, Andrea
Mazziotti, Gherardo
Torri, Valter
Spinello, Maurizio
Floriani, Irene
Melmed, Shlomo
[J]. PLOS ONE, 2012, 7 (05):
[16] Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly
Heck, Ansgar
Emblem, Kyrre E.
Casar-Borota, Olivera
Bollerslev, Jens
Ringstad, Geir
[J]. ENDOCRINE, 2016, 52 (02) : 333 - 343
[17] PITUITARY-ADENOMAS WITH INVASION OF THE CAVERNOUS SINUS SPACE - A MAGNETIC-RESONANCE-IMAGING CLASSIFICATION COMPARED WITH SURGICAL FINDINGS
KNOSP, E
STEINER, E
KITZ, K
MATULA, C
[J]. NEUROSURGERY, 1993, 33 (04) : 610 - 618
[18] Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly?: A randomized study
Kristof, RA
Stoffel-Wagner, B
Klingmüller, D
Schramm, J
[J]. ACTA NEUROCHIRURGICA, 1999, 141 (04) : 399 - 405
[19] Preoperative lanreotide treatment for GH-secreting pituitary adenomas:: effect on tumour volume and predictive factors of significant tumour shrinkage
Lucas, T
Astorga, R
Catalá, M
[J]. CLINICAL ENDOCRINOLOGY, 2003, 58 (04) : 471 - 481
[20] Presurgical treatment with somatostatin analogues in growth hormone-secreting pituitary adenomas: A long-term single-center experience
Lv, Liang
Hu, Yu
Zhou, Peizhi
Zhang, Shizhen
Yin, Senlin
Zhang, Nannan
Jiang, Shu
[J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 167 : 24 - 30

← 1 2 3 →